IFN/STAT1 signaling potentiates cell cycle arrest and apoptosis in tumor cells, induces angiostatic responses, increases antigen processing and presentation by tumor cells, and primes the innate and adaptive immune cells to activate immune cell subsets (Th1/CTL; NK) that promote anti-tumor immunity. Here, IFNA1 is linked to neoplasm.